Kentaro Moriichi Selected Research

RNA-Binding Proteins (RNA-Binding Protein)

6/2021	The Identification of RNA-Binding Proteins Functionally Associated with Tumor Progression in Gastrointestinal Cancer.
1/2020	A tumor-specific modulation of heterogeneous ribonucleoprotein A0 promotes excessive mitosis and growth in colorectal cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kentaro Moriichi Research Topics

Disease

19	Neoplasms (Cancer) 03/2024 - 09/2008
9	Colitis 01/2021 - 11/2011
8	Crohn Disease (Crohn's Disease) 01/2024 - 06/2007
8	Inflammation (Inflammations) 01/2022 - 08/2012
7	Colorectal Neoplasms (Colorectal Cancer) 10/2022 - 04/2010
6	Ulcerative Colitis 01/2024 - 12/2015
5	Hemorrhage 05/2024 - 10/2011
5	Stomach Neoplasms (Stomach Cancer) 03/2024 - 05/2012
4	Adenocarcinoma 03/2024 - 12/2010
4	Infections 07/2023 - 03/2009
4	Colonic Neoplasms (Colon Cancer) 10/2016 - 04/2010
3	Carcinoma (Carcinomatosis) 03/2024 - 09/2013
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 01/2018
3	Carcinogenesis 01/2021 - 03/2009
2	Esophageal Neoplasms (Esophageal Cancer) 03/2024 - 06/2021
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 03/2024 - 06/2021
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2024 - 01/2016
2	Weight Loss (Weight Reduction) 03/2024 - 02/2010
2	Sarcoidosis (Schaumann Disease) 01/2024 - 10/2021
2	Lymphoma (Lymphomas) 09/2022 - 07/2011
2	Pathologic Constriction (Stenosis) 03/2022 - 01/2019
2	Wounds and Injuries (Trauma) 11/2021 - 07/2015
2	Polyps 02/2014 - 10/2011
2	Microsatellite Instability 05/2012 - 03/2009
1	Latent Tuberculosis 07/2023
1	Latent Infection 07/2023
1	Atrial Fibrillation 10/2022
1	T-Cell Lymphoma (Lymphoma, T Cell) 09/2022
1	Cytomegalovirus Infections (Inclusion Disease) 09/2022
1	Gastritis 07/2022
1	Malnutrition (Nutritional Deficiencies) 03/2022
1	Vomiting 03/2022
1	Diverticular Diseases 01/2022
1	Chemical and Drug Induced Liver Injury 01/2022
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022
1	Cholestasis 01/2022
1	Jaundice (Icterus) 01/2022
1	Liver Diseases (Liver Disease) 01/2022
1	Melanoma (Melanoma, Malignant) 01/2022
1	Pancreatitis 11/2021
1	Pulmonary Sarcoidosis 10/2021
1	Adenoma (Adenomas) 01/2021
1	Colitis-Associated Neoplasms 01/2021

Drug/Important Bio-Agent (IBA)

6	Messenger RNA (mRNA)IBA 10/2022 - 07/2015
5	Small Interfering RNA (siRNA)IBA 10/2022 - 06/2013
5	PolyphosphatesIBA 11/2021 - 08/2015
4	FerrichromeIBA 03/2024 - 10/2016
4	Heterogeneous-Nuclear Ribonucleoproteins (Informatin)IBA 10/2022 - 11/2015
4	Infliximab (Remicade)FDA Link 01/2022 - 01/2013
4	Biomarkers (Surrogate Marker)IBA 08/2021 - 03/2009
4	sodium sulfate (sodium bisulfate)FDA LinkGeneric 08/2015 - 11/2011
4	Dextrans (Dextran)FDA Link 08/2015 - 11/2011
3	SteroidsIBA 09/2022 - 01/2019
3	RibonucleoproteinsIBA 06/2020 - 11/2015
2	carbazochrome (Adona)IBA 05/2024 - 10/2022
2	Fluorouracil (Carac)FDA LinkGeneric 03/2024 - 01/2021
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2023 - 01/2021
2	Immune Checkpoint InhibitorsIBA 07/2022 - 01/2022
2	CT-P13IBA 01/2022 - 10/2021
2	heptelidic acidIBA 01/2022 - 01/2021
2	NivolumabIBA 01/2022 - 01/2019
2	Biosimilar PharmaceuticalsIBA 01/2022 - 10/2021
2	RNA-Binding Proteins (RNA-Binding Protein)IBA 06/2021 - 01/2020
2	AntibodiesIBA 01/2021 - 07/2015
2	Dextran SulfateIBA 01/2021 - 01/2021
2	RNA (Ribonucleic Acid)IBA 01/2020 - 11/2015
2	MicroRNAs (MicroRNA)IBA 01/2018 - 06/2013
2	Indicators and Reagents (Reagents)IBA 11/2017 - 12/2015
2	DNA (Deoxyribonucleic Acid)IBA 07/2016 - 04/2010
2	Heterogeneous Nuclear Ribonucleoprotein A1IBA 11/2015 - 07/2015
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 08/2015 - 06/2013
2	CollagenIBA 08/2015 - 02/2010
2	Proteins (Proteins, Gene)FDA Link 07/2015 - 03/2011
2	Cadherins (E-Cadherin)IBA 09/2013 - 03/2009
2	Monoclonal AntibodiesIBA 05/2012 - 03/2009
1	lissamine rhodamine B (sulforhodamine B)IBA 03/2024
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2024
1	pro-brain natriuretic peptide (1-76)IBA 01/2024
1	vedolizumabIBA 07/2023
1	Warfarin (Coumadin)FDA LinkGeneric 10/2022
1	Heparin (Liquaemin)FDA LinkGeneric 10/2022
1	C-Reactive ProteinIBA 09/2022
1	Glyceraldehyde-3-Phosphate Dehydrogenases (GAPD)IBA 01/2022
1	SesquiterpenesIBA 01/2022
1	Tumor Necrosis Factor InhibitorsIBA 01/2022
1	LactonesIBA 01/2022
1	CeruletideIBA 11/2021
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 08/2021

Therapy/Procedure

15	Therapeutics 01/2024 - 12/2010
5	Drug Therapy (Chemotherapy) 09/2022 - 11/2015
3	Blood Component Removal (Apheresis) 01/2024 - 08/2021
3	Remission Induction 01/2024 - 08/2021
2	Gastrostomy 03/2022 - 03/2011
2	Gastrectomy 09/2020 - 09/2008
2	Colectomy 07/2020 - 10/2013
2	Appendectomy 10/2013 - 10/2011
1	Hematopoietic Stem Cell Transplantation 09/2022
1	Radiotherapy 09/2022
1	Punctures 03/2022
1	Ligation 01/2022